Adaptimmune Therapeutics PLC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
Adaptimmune Therapeutics announces its 2025 Annual General Meeting to be held on May 29, 2025, in Abingdon, Oxfordshire, U.K.
Adaptimmune Therapeutics announces its Annual General Meeting (AGM) will be held on May 14, 2024, to vote on director re-elections, auditor appointments, executive compensation, and share allotment authorizations.